Mechanical Ventilation and Respiratory Muscle Work of Breathing in Acute Respiratory Distress Syndrome (ARDS) Patients
The Role of Diaphragm Electromyography (EMG) Guided Mechanical Ventilation on Respiratory Physiology in Mechanically Ventilated Patients With Acute Respiratory Distress Syndrome (ARDS)
1 other identifier
interventional
12
1 country
1
Brief Summary
The purpose of this study is to demonstrate that mechanical ventilation guided by the diaphragm EMG signal (also know as neurally adjusted ventilatory assist \[NAVA\]) is superior compared to pressure support and pressure control ventilation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2011
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 27, 2011
CompletedFirst Posted
Study publicly available on registry
February 4, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedJune 10, 2015
June 1, 2015
2.2 years
January 27, 2011
June 9, 2015
Conditions
Outcome Measures
Primary Outcomes (2)
Pressure-time product of the diaphragm
The pressure-time product of the transdiaphragmatic pressure (Pdi) during inspiration is obtained for each breath by multiplying the corresponding mean inspiratory Pdi signal above the end-expiratory baseline by the inspiration time. Breath-by-breath data are ensemble-averaged over the last 15 minutes of each study arm.
average of last 15 minutes of each study arm
Patient - ventilator asynchrony index
Ventilator asynchrony is determined as the sum of the triggering and cycling-off delays per breath, expressed as a percentage of the total breath duration. The trigger delay is measured as the time difference between the onset of neural inspiration and the ventilator inspiratory flow, and the cycling delay as the time difference between the end of neural inspiration and the end of ventilator inspiratory flow. Breath-by-breath data are ensemble-averaged over the last 15 minutes of each study arm.
average of last 15 minutes of each study arm
Secondary Outcomes (4)
Transpulmonary pressure
average of last 15 minutes of each study arm
Transdiaphragmatic pressure
average of last 15 minutes of each study arm
Oxygenation index
at the end of each study arm
Dead space ventilation
average of last 15 minutes of each study arm
Study Arms (4)
Pressure support ventilation, ARDSnet
ACTIVE COMPARATORMechanical ventilator is set to pressure support ventilation (6 ml/kg) for 30 min with positive end expiratory pressure (PEEP) set according to the "higher arm" of the ARDS network consensus.
Pressure control ventilation, ARDSnet
ACTIVE COMPARATORMechanical ventilator is set to pressure control ventilation (6 ml/kg) for 30 min with PEEP set according to the "higher arm" of the ARDS network consensus.
Neurally adjusted ventilatory assist, ARDSnet
ACTIVE COMPARATORMechanical ventilator is set to NAVA for 30 min with PEEP set according to the "higher arm" of the ARDS network consensus.
Neurally adjusted ventilatory assist, titrated
ACTIVE COMPARATORMechanical ventilator is set to NAVA for 30 min with PEEP titrated using the diaphragm EMG signal.
Interventions
The mechanical ventilator is set to different ventilation modes as described in the individual arms.
Eligibility Criteria
You may qualify if:
- intubated, mechanically ventilated patients
- meeting criteria for ARDS
- mean arterial blood pressure \> 65 mmHg (with or w/o vasopressors)
You may not qualify if:
- pregnancy
- increased intracranial pressure
- contra-indication naso-gastric tube
- diagnosed neuro-muscular disorder
- recent (\<12 hours) use of muscle relaxants
- open chest or- abdomen
- very high inspiratory flow rate during supported ventilation
- inability to obtain informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Center Nijmegen
Nijmegen, Gelderland, 6525 GA, Netherlands
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Leo Heunks, MD, PhD
Radboud University Nijmegen Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD PhD
Study Record Dates
First Submitted
January 27, 2011
First Posted
February 4, 2011
Study Start
January 1, 2011
Primary Completion
March 1, 2013
Study Completion
March 1, 2013
Last Updated
June 10, 2015
Record last verified: 2015-06